Superdisintegrants Market Size by Product Type, Formulation, Therapeutic Area, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2034
Overview
The Superdisintegrants Market size was valued at USD 485.54 Million in 2025 and the total Superdisintegrants revenue is expected to grow at a CAGR of 7.62% from 2026 to 2034, reaching nearly USD 940.29 Million.
Superdisintegrants Market Dynamics:
Disintegrants are mixture used to prepare tablets formulation to ensure the rapid break down into smaller particles that facilitate the dissolution more rapidly and release of the active ingredients. Rising adoption of orally disintegrating tablets and the emergence of new superisintegrants for the pharmaceutical industry are increasing the growth of the market. Pharmaceutical market expansion in emerging countries is a key opportunity of the market. However, safety and quality concerns are limiting the growth of the superdisintegrants market.
Global Superdisintegrants Size Share & Growth Analysis
To know about the Research Methodology:-Request Free Sample Report
The synthetic superdisintegrant segment held the largest share of the global superdisintegrants market owing to the prevalent use of excipients such as sodium starch glycolate, and crospovidone in orally & fast disintegrating tablets. Increasing incidences of cardiac diseases, neurological infections are also expected to drive the demand of synthetic segment in global superdisintegrants market. Although synthetic superdisintegrants have been the ordinary for many decades now, greater research into natural superdisintegrants will drive for the future growth of the superdisintegrants market. Natural polymers will drive the market growth during the forecast period owing to the increased solubility of poorly water soluble drug. Natural polymers increase the properties of the tablet due to the presence of natural polymers such as Mangifera indica gum, Hibiscus Rosa sinenses mucilage, dehydrated banana powder, orange peel pectin, and Locust bean gum.
The tablets segment is estimated to account for the largest share of the superdisintegrants market owing to the rising stability, low manufacturing cost as compared to other dosage forms such as capsules, and mouth-dissolving films. Easy product identification and solidity of the product are driving the production of tablet formulations. Moreover, an increasing focus on fast and orally disintegrating tablets are also contributing to the large share of tablets segment in the superdisintegrants market.
The neurological diseases segment is projected to the largest share in 2025, owing to the growing incidences of neurological disorders has led to a rise in the demand for effective therapies, which has further led to the increasing use of over-the-counter in the treatment of neurological disorders.
Gastrointestinal diseases include the diseases namely the oesophagus, stomach, small intestine, large intestine and rectum. Gastrointestinal diseases are becoming more common in the developing region, with symptoms like nausea, vomiting, abdominal pain, reduced appetite, bloating, swallowing difficulties, and heartburn.
North America is leading the market owing to the growing financial support for the development of innovative oral dosage forms. The Asia Pacific is expected to grow the fastest rate during the forecast period owing to the growing healthcare spending, increasing healthcare infrastructure & awareness and rising outsourcing of excipient manufacturing to Asia Pacific countries such as India & China. Low-cost manufacturing advantage, growing per capita income, low regulatory stringency, and rising interest of key players in APAC countries are also expected to grow the market in this region.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global superdisintegrants market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in global superdisintegrants market.
Recent Industry Development :
| Date | Company | Development | Impact |
|---|---|---|---|
| 16 September 2025 | Sigachi Industries | Sigachi Industries announced plans to commission a new croscarmellose sodium (CCS) facility in Dahej, Gujarat, having secured environmental clearance for the expansion. | The strategic expansion complements its flagship microcrystalline cellulose portfolio to deliver comprehensive superdisintegrant and excipient solutions for oral solid dosage drug manufacturing. |
| 04 November 2025 | Roquette Frères | Roquette presented its expanded pharmaceutical portfolio at AAPS 2025 PharmSci 360, showcasing novel plant-based orally disintegrating film platforms and superdisintegrant excipient innovations. | The showcase highlighted advanced formulation technologies designed to solve drug solubility challenges and support sustainable, high-speed tablet compression. |
| 17 February 2026 | DFE Pharma | DFE Pharma launched a new Continuous Manufacturing (CM) platform featuring CM-ready excipients at its C2F Center of Excellence in Hyderabad, India. | The facility accelerates formulation testing for croscarmellose and superdisintegrant-based tablets, enabling pharmaceutical clients to transition seamlessly to high-throughput continuous manufacturing. |
| 10 June 2026 | Ashland Inc. | Ashland expanded technical support capabilities for its Polyplasdone™ crospovidone superdisintegrants to target growing demand in pediatric and geriatric orally disintegrating tablets (ODTs). | The effort strengthens Ashland’s leadership in North American pharmaceutical manufacturing by offering particle-engineered grades that improve flow properties and rapid dissolution under high-speed compression. |
| 18 August 2026 | BASF SE | BASF scaled up regional supply chains for its Kollidon® CL crospovidone product line to address rising regulatory compliance standards in Asian and North American generic markets. | The initiative optimizes global distribution of high-efficiency superdisintegrants to meet surged demand driven by expanded generic drug approvals and plant-derived excipient requirements. |
Global Superdisintegrants Market, Key Highlights:
1. Global Superdisintegrants Market analysis and forecast, in terms of value.
2. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Superdisintegrants Market
3. Global Superdisintegrants Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.
4. Global Superdisintegrants Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.
5. Global Superdisintegrants Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
6. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.
7. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Market are also profiled.
Global Superdisintegrants Market Scope: Inquire before buying
| Global Superdisintegrants Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2026: | USD485.54 Mn. |
| Forecast Period 2026 to 2034 CAGR: | 7.62% | Market Size in 2034: | USD 940.29 Mn. |
| Segments Covered: | by Product Type | Natural Superdisintegrants Synthetic Superdisintegrants Other |
|
| by Formulation | Tablets Capsules Mouth-dissolving Films |
||
| by Therapeutic Area | Gastrointestinal Diseases Neurological Diseases Oncology Infectious Diseases Cardiovascular Diseases Hematological Diseases Inflammatory Diseases |
||
Global Superdisintegrants Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Global Superdisintegrants Market Key Players:
1. Ashland
2. BASF SE
3. FMC Corporation
4. JRS Pharma
5. DFE Pharma
6. Roquette
7. The Dow Chemical Company
8. Asahi Kasei Corporation
9. Nippon Soda Co
10.Huber Corporation
11.DowDuPont
12.Merck KGaA
13.Corel Pharma Chem
14.Avantor Performance Materials, LLC
Frequently Asked Questions:
1. Which region has the largest share in Global Superdisintegrants Market?
Ans: Asia Pacific region holds the highest share in 2025.
2. What is the growth rate of Global Superdisintegrants Market?
Ans: The Global Superdisintegrants Market is growing at a CAGR of 7.62% during forecasting period 2026-2034.
3. What is scope of the Global Superdisintegrants market report?
Ans: Global Superdisintegrants Market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Superdisintegrants market?
Ans: The important key players in the Global Superdisintegrants Market are – Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co, Huber Corporation, DowDuPont, Merck KGaA, Corel Pharma Chem, Avantor Performance Materials, and LLC.
5. What was the Global Superdisintegrants Market size in 2025?
Ans: The Global Superdisintegrants Market size was USD 485.54 Million in 2025.